Plus Therapeutics, Inc. (PSTV) Misses Q2 EPS by 1c

Plus Therapeutics, Inc. (NASDAQ: PSTV) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Plus Therapeutics, Inc. (PSTV) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Choiceone Financial Services, Inc. (COFS) Misses Q2 EPS by 5c
• American Express (AXP) Tops Q2 EPS by 13c